Smartest Doc
Gilead sciences announces second quarter 2012 financial results Full Text
Gilead, 07/27/2012
Gilead Sciences, Inc. announced its results of operations for the quarter ended June 2012. Total revenues for the second quarter of 2012 increased 13 percent to $2.41 billion, from $2.14 billion for the second quarter of 2011. Net income for the second quarter of 2012 was $711.6 million, or $0.91 per diluted share compared to $746.2 million, or $0.93 per diluted share for the second quarter of 2011. Non–GAAP net income for the second quarter of 2012, which excludes acquisition–related, restructuring and stock–based compensation expenses, was $767.3 million, or $0.99 per diluted share compared to $797.7 million, or $1.00 per diluted share for the second quarter of 2011.